Changes of the immunogenic properties of K36 lymphoma treated in vivo with 5(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (DTIC).
D000406:AKR murine leukemia virus; D000818:Animals; D000951:Antigens, Neoplasm; D003606:Dacarbazine / Q000627:therapeutic use*; D006084:Graft Rejection; D006648:Histocompatibility; D007942:Leukemia, Experimental / Q000188:drug therapy / Q000276:immunology*; D051379:Mice; D008806:Mice, Inbred AKR; D009368:Neoplasm Transplantation; D014184:Transplantation, Homologous; D014185:Transplantation, Isogeneic
D000951:Antigens, Neoplasm; D003606:Dacarbazine